Ignite Creation Date:
2024-05-06 @ 12:00 PM
Last Modification Date:
2024-10-26 @ 12:53 PM
Study NCT ID:
NCT03658772
Status:
COMPLETED
Last Update Posted:
2023-10-24
First Post:
2018-08-24
Brief Title:
Grapiprant and Pembrolizumab in Patients With Advanced or Progressive MSS Colorectal Cancer
Sponsor:
Arrys Therapeutics
Organization:
Arrys Therapeutics
Organization Data
Organization:
Arrys Therapeutics
Class:
INDUSTRY
Study ID:
ARYS-001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Arrys Therapeutics
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Merck Sharp Dohme LLC | INDUSTRY |